Journey Medical Valuation

DERM Stock  USD 4.55  0.57  14.32%   
At this time, the firm appears to be undervalued. Journey Medical Corp retains a regular Real Value of $5.75 per share. The prevalent price of the firm is $4.55. Our model calculates the value of Journey Medical Corp from evaluating the firm fundamentals such as Current Valuation of 92.41 M, return on equity of -1.3, and Return On Asset of -0.17 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Journey Medical's valuation include:
Price Book
8.6994
Enterprise Value
92.4 M
Enterprise Value Ebitda
17.7192
Price Sales
1.6453
Forward PE
90.9091
Undervalued
Today
4.55
Please note that Journey Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Journey Medical Corp is based on 3 months time horizon. Increasing Journey Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Journey stock is determined by what a typical buyer is willing to pay for full or partial control of Journey Medical Corp. Since Journey Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Journey Stock. However, Journey Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.55 Real  5.75 Target  10.0 Hype  4.51 Naive  4.54
The intrinsic value of Journey Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Journey Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
5.75
Real Value
9.53
Upside
Estimating the potential upside or downside of Journey Medical Corp helps investors to forecast how Journey stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Journey Medical more accurately as focusing exclusively on Journey Medical's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
0.734.518.29
Details
Naive
Forecast
LowNext ValueHigh
0.774.548.32
Details
4 Analysts
Consensus
LowTarget PriceHigh
9.1010.0011.10
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Journey Medical's intrinsic value based on its ongoing forecasts of Journey Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Journey Medical's closest peers.

Journey Medical Cash

23.46 Million

Journey Valuation Trend

Knowing Journey Medical's actual value is paramount for traders when making sound investment determinations. Using both Journey Medical's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Journey Revenue by Product

Journey Medical Total Value Analysis

Journey Medical Corp is currently projected to have valuation of 92.41 M with market capitalization of 95.05 M, debt of 17.73 M, and cash on hands of 38.14 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Journey Medical fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
92.41 M
95.05 M
17.73 M
38.14 M

Journey Medical Investor Information

About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.92. Journey Medical Corp had not issued any dividends in recent years. Journey Medical Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.

Journey Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Journey Medical has an asset utilization ratio of 103.03 percent. This suggests that the Company is making $1.03 for each dollar of assets. An increasing asset utilization means that Journey Medical Corp is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid

Journey Medical Ownership Allocation

The market capitalization of Journey Medical is $95.05 Million. Journey Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Journey Medical Profitability Analysis

The company reported the previous year's revenue of 79.18 M. Net Loss for the year was (3.85 M) with profit before overhead, payroll, taxes, and interest of 33.11 M.

About Journey Medical Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Journey Medical Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Journey Medical Corp based exclusively on its fundamental and basic technical indicators. By analyzing Journey Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Journey Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Journey Medical. We calculate exposure to Journey Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Journey Medical's related companies.
Last ReportedProjected for Next Year
Gross Profit60.4 M63.4 M
Pretax Profit Margin(0.04)(0.04)
Operating Profit Margin(0.02)(0.02)
Net Loss(0.04)(0.05)
Gross Profit Margin 0.76  0.75 

Journey Medical Growth Indicators

Investing in growth stocks can be very risky. If the company such as Journey Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding18.2 M
Forward Price Earnings90.9091

Journey Medical Current Valuation Indicators

Journey Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Journey Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Journey Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Journey Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Journey Medical's worth.
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
2.921
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.17)
Return On Equity
(1.30)
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.